pharmacology studies of 1-beta-d-arabinofuranosylcytosine in pediatric patients with leukemia and lymphoma after a biochemically optimal regimen of loading bolus plus continuous infusion of the drug .
C0010711
arabinofuranosylcytosine
C0024299
lymphoma